Spain's Ministry of Health published the draft royal decree to allow the prescription of cannabis preparations back in ...

Brits travelling to Spain could have some new rules to navigate as the country looks closer to changing the law around drugs ...

ALAN CARR fears an eye condition will ruin his eyesight after having a “worrying” diagnostic test. The 48-year-old Chatty Man ...

The drug could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases.

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. The Mayo Clinic says MS causes the breakdown of the protective covering of nerve fibers, known as ...

Before losing more than four stone, Susan felt constantly tired, sore and was worried about her health. After suffering issues with her legs, doctors suspected she may have Multiple Sclerosis ...

FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.

A West Lothian woman’s weight loss journey has been nothing short of transformative. Prior to her weight loss, Susan Duffin felt constantly tired, sore, and worried about her health. The turning point ...

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...